Handbook of Clinical medicine

Resemble Machupo) Lassa fever. Severe disease with bleeding in Brazilian HF (Sabia) ~ ⅓ . Supportive treatment. Live vaccine avail- able for Junin virus. Venezualan HF (Guanarito) Bunyavirus Crimean-Congo HF See CCHF, p427 Hanta Rodent host. Incubation 2d-8wk. Causes: 1 HF with renal syndrome: fever, headache, GI symptoms, and AKI. 2 Hanta virus pulmonary syndrome: bilateral interstitial pulmonary infi ltrates, mortality 30–40%. Supportive treatment. Rift valley fever Endemic in Africa. 80% asymptomatic or self-limiting febrile illness. <2% CNS involve- ment/haemorrhagic. Flavivirus Dengue see p420 Yellow fever see p420 The Advisory Committee on Dangerous Pathogens (ACDP) classifi es a pathogen as Group 4 (highest) when it causes severe human disease, with high risk of spread, and no eff ective prophy- laxis or treatment. Ebola,19 Mar- burg, Lassa, and Crimean-Congo haemorrhagic fever (CCHF) are all Hazard Group 4 haemorrhagic fever viruses. They are largely confi ned to Africa (fi g 9.35), with Fig 9.35 VHF risk in Africa. the exception of CCHF which oc- Reproduced with permission from Viral haemorrhagic curs in Africa, the Middle East, fevers: origins, reservoirs, transmission and guidelines, Crown Eastern Europe, and Asia. copyright 2016. Contains public sector information licensed Ebola under the Open Government Licence v3.0. Incubation
